Latest Administration News

Plato Income Maximiser Limited has reported a robust financial year ending June 2025, with net profit after tax rising to $83.6 million and its investment portfolio outperforming the benchmark in both income and total return. The company also maintained its highest-ever fully franked monthly dividends since listing.

Health and Plant Protein Group Limited (HPP) reported a reduced net loss of $528,000 for FY2025, following the receipt of final proceeds from its US divestment. The Board signals plans to return capital and pursue new corporate opportunities.

Universal Biosensors Inc. has been suspended from ASX trading following the appointment of voluntary administrators, highlighting serious financial distress within the company.

Cannindah Resources announces the resignation of Managing Director Tom Pickett and appoints Cam Switzer as Interim CEO, signaling a new phase for the Mt Cannindah copper and gold project.

The ASX has suspended the securities of 36 companies for failing to pay their annual listing fees by the August 21 deadline, with a looming delisting threat if fees remain unpaid by August 28.

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

Inghams Group reported a stable underlying EBITDA of $236.4 million for FY25 despite softer market conditions and customer changes, while guiding for a modest earnings dip in FY26 as cost reduction programs take effect.

Guzman y Gomez (GYG) has reported a record FY25 with $1.2 billion in network sales and a 152% jump in net profit, underpinned by strong comp sales growth and rapid restaurant expansion. The company also declared its first dividend and outlined ambitious plans for continued growth and margin improvement.

Inghams Group Limited reported a 3.4% revenue decline and an 11.5% drop in net profit for FY25, impacted by a new Woolworths supply agreement and lease accounting changes, while maintaining stable underlying earnings and declaring an 8-cent fully franked final dividend.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

BSP Financial Group reported a solid 9.8% increase in net profit for the half year ended June 2025, underpinned by growth in net interest income, fees, and foreign exchange earnings. The Group also restructured its Fiji operations into a wholly owned subsidiary, enhancing its regional footprint and regulatory compliance.

Brazilian Critical Minerals secures robust support from Amazonas state and local authorities for its Ema Rare Earth Project, advancing environmental permitting with unanimous community approval.